Philadelphia– Integral Molecular, a leader in providing essential research tools that enable vaccine development, proudly announces the achievement of ISO 9001 certification for the quality systems and processes used in their virology offerings. With over 20 years of experience and 100+ peer-reviewed publications in virology, Integral Molecular is a trusted partner for researchers and pharmaceutical […]
Molecular Devices is the world’s only company offering a service to manufacture standardized, quality-tested patient-derived organoids at a scale of many millions per batch SAN JOSE, Calif., and CARDIFF, Wales – Today, Molecular Devices, LLC., a leading high-performance life science solutions provider, officially opened its custom-built site in Cardiff, UK. The multi-million-pound facility was custom-built for the […]
Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells Cambridge, UK — Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect®PLUS. In conjunction with the Company’s Cyto-Mine® platform, the new assay provides a streamlined method to measure antibody […]
This unprecedented approach integrates genomic, proteomic, and clonotypic assessment of subclonal multiple myeloma and its precursor stages Late-breaking data on clonal tracking in smoldering to active myeloma progression presented at the European Hematology Association (EHA) show on June 14 SOUTH SAN FRANCISCO, Calif. — Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, […]
Quebec City, Canada – Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable figures including Martin […]
Siren Biotechnology to receive products, technologies and contract testing services to develop gene therapy treatments for cancer Experts from MilliporeSigma’s Emprove® team and M Lab™ Collaboration Center to provide consultation and training Company has awarded grants to 40-plus biotechnology companies since 2014 BURLINGTON, Mass. — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, […]
New tools will advance study—and hopefully treatment—of common genetic heart conditions. For every 500 people reading this, one likely has a disease called hypertrophic cardiomyopathy (HCM). It is the most common genetic heart condition in the world, primarily caused by mutations that thicken heart muscle and, in rare cases, lead to heart failure and cardiac […]
QUEBEC CITY — Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable figures including Martin Leblanc, […]
GMP-compliant 50L and 250L SUPRs support large-scale recombinant antibody production Morgan Hill, USA and Delft, Netherlands: Aragen Bioscience, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, and Getinge, a Swedish life sciences products and solutions provider, today announced the successful validation of latter’s Single-Use Production Reactors (SUPR) for large-scale recombinant […]
NEW YORK – Trilantic North America, a growth-focused middle market private equity firm, announced today that it has made a substantial growth investment in SOFIE Biosciences (“SOFIE” or the “Company”), a founder-led radiopharmacy and contract development and manufacturing organization. The investment was made in partnership with SOFIE’s founding team, who will retain a meaningful equity […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
